Yuedan Chen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy of individualized orelabrutinib-based regimens in relapsed or refractory central nervous system lymphoma.
Journal: Frontiers in neurology
Published: February 03, 2025
Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China.
Journal: Frontiers in oncology
Published: October 10, 2021
Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
Journal: Chinese neurosurgical journal
Published: September 17, 2020
Expression of hypoxia-inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors.
Journal: Brain and behavior
Published: March 11, 2020
Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population.
Journal: BMC neurology
Published: June 28, 2019
Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature.
Journal: Chinese neurosurgical journal
Published: November 08, 2017
Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
Journal: Oncotarget
Published: December 21, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026